Data / Research funding / Lymphedema
Lymphedema: 70 NIH awards ($57.8M) to 38 organizations
70 NIH awards ($57.8M) in the NIH spending category Lymphedema, to 38 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
70 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,522,987 | July 5, 2016 | May 31, 2027 | CHEN, HONG | reporter.nih.gov |
| VEGFR Signaling Controls Lymphatic Junctions | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,637,007 | July 1, 2022 | June 30, 2027 | SCALLAN, JOSHUA PAUL | reporter.nih.gov |
| A Critical Role for Hypoxia-Inducible Factors in Lymphedema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,285,302 | August 1, 2021 | July 31, 2025 | JIANG, XINGUO | reporter.nih.gov |
| Mapping & quantifying lymphatic drainage of the arm's alternate pathway | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,188,750 | January 26, 2021 | December 31, 2026 | SINGHAL, DHRUV | reporter.nih.gov |
| Mechanisms of racial disparity in breast cancer-related lymphedema | NIH | National Cancer Institute | 2023 to 2025 | $2,166,923 | January 1, 2023 | December 31, 2027 | MEHRARA, BABAK J | reporter.nih.gov |
| Cardiovascular potassium channels: From molecular basis to disease therapeutics | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,160,901 | January 1, 2024 | December 31, 2030 | NICHOLS, COLIN G | reporter.nih.gov |
| Visualizing vascular mechanisms of lipedema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,023,233 | April 20, 2021 | October 21, 2024 | CRESCENZI, RACHELLE L | reporter.nih.gov |
| Retinoic Acid Induced Lymphangiogenesis for Post-surgical Lymphedema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,961,343 | September 1, 2021 | November 30, 2023 | WONG, ALEX K. | reporter.nih.gov |
| Imaging sodium and lymphatics in lymphedema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,947,844 | January 25, 2021 | October 31, 2024 | CRESCENZI, RACHELLE L | reporter.nih.gov |
| Lymphatic pacemaking and pumping in lymphedema: function, dysfunction, and rescue | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,896,927 | April 1, 2015 | December 31, 2024 | DAVIS, MICHAEL JOHN | reporter.nih.gov |
| Pro-resolving lipid mediators in immunity and vascular biology | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,573,911 | August 1, 2011 | June 30, 2025 | SPITE, MATTHEW R | reporter.nih.gov |
| Lymphatic Regeneration by Direct Cellular Reprogramming | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,552,332 | July 1, 2023 | June 30, 2027 | YOON, YOUNG-SUP | reporter.nih.gov |
| Molecular Mechanisms Regulating Neuropilin 2 in Lymphangiogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,529,278 | January 18, 2019 | December 31, 2023 | BIELENBERG, DIANE RENEE | reporter.nih.gov |
| Lymphedema therapy via lymphatic targeted drug delivery | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,322,102 | April 1, 2024 | February 28, 2028 | THOMAS, SUSAN NAPIER | reporter.nih.gov |
| Site-1 protease-mediated lipid metabolism in lymphatic vascular development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,311,000 | August 1, 2020 | May 31, 2025 | XIA, LIJUN | reporter.nih.gov |
| Pathways Regulating Lymphatic Vessel Permeability and Valve Formation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,287,720 | May 24, 2019 | April 30, 2025 | SCALLAN, JOSHUA PAUL | reporter.nih.gov |
| Retinoic Acid Induced Lymphangiogenesis for Post-Surgical Lymphedema | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,232,103 | September 1, 2021 | August 31, 2027 | WONG, ALEX K. | reporter.nih.gov |
| Regulation of lymphatic muscle cell function by store operated calcium entry signaling | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,153,370 | August 1, 2024 | June 30, 2029 | ZAWIEJA, SCOTT D. | reporter.nih.gov |
| Molecular mechanisms enhancing lymphatic valve formation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,136,508 | February 1, 2019 | January 31, 2025 | YANG, YING | reporter.nih.gov |
| Development of a Bioengineered Therapeutic Device for the Prevention of Lymphedema | NIH | National Cancer Institute | 2024 to 2025 | $1,097,160 | July 8, 2024 | June 30, 2029 | HUANG, NGAN F. | reporter.nih.gov |
| A Critical Role for Leukotriene B4 in Lymphedema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,056,807 | January 21, 2019 | December 31, 2024 | NICOLLS, MARK ROBERT | reporter.nih.gov |
| Ryanodine Receptors as Therapeutic Targets to Prevent Doxorubicin-Induced Lymphatic Dysfunction | NIH | National Cancer Institute | 2023 to 2025 | $1,054,741 | August 10, 2023 | July 31, 2028 | STOLARZ, AMANDA | reporter.nih.gov |
| Lymphedema Prevention Through Immediate Lymphatic Reconstruction | NIH | National Cancer Institute | 2024 to 2025 | $1,023,990 | August 1, 2024 | July 31, 2026 | SCHAVERIEN, MARK V | reporter.nih.gov |
| Mechanisms of fibrosis in post-surgical lymphedema | NIH | National Heart, Lung, and Blood Institute | 2021 | $897,335 | September 1, 2012 | November 30, 2022 | MEHRARA, BABAK J | reporter.nih.gov |
| Controlling Neuropilin-2 Signaling to Improve Lymphatic Function | NIH | National Heart, Lung, and Blood Institute | 2025 | $865,694 | June 5, 2025 | April 30, 2029 | BIELENBERG, DIANE RENEE | reporter.nih.gov |
| Ergonomic fluorescence-guided surgery imaging platform for intraoperative assessment of blood and lymphatic vasculature | NIH | National Cancer Institute | 2021 | $822,516 | July 21, 2016 | August 31, 2023 | USELMANN, ADAM JOHN | reporter.nih.gov |
| Imaging Biomarkers of Lymphatic Dysfunction | NIH | National Institute of Nursing Research | 2021 to 2022 | $790,000 | July 14, 2014 | January 31, 2025 | DONAHUE, MANUS J | reporter.nih.gov |
| Novel approached to prevent diet-induced obesity via lacteal junctions | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $753,750 | July 1, 2019 | April 30, 2024 | EICHMANN, ANNE CHRISTINE | reporter.nih.gov |
| The Regulation of Lymphatic Muscle Cell Pacemaking by Intracellular Calcium Signals | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $746,644 | August 1, 2021 | July 31, 2024 | ZAWIEJA, SCOTT D. | reporter.nih.gov |
| Enhancing immunity by protecting lymphatic muscle cells from MRSA-Induced dysfunction | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $740,780 | July 2, 2024 | June 30, 2029 | JONES, DENNIS | reporter.nih.gov |
| Harvard MD Anderson Collaborative to Reduce LyMphatic MOrbidity in Head and Neck Cancer with Artificial Intelligence (HARMONiC-AI) | NIH | National Institute of Dental & Craniofacial Research | 2025 | $732,513 | April 8, 2025 | January 31, 2030 | FULLER, CLIFTON DAVID | reporter.nih.gov |
| Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors with Chronic Lymphedema | NIH | National Cancer Institute | 2025 | $706,669 | April 23, 2025 | March 31, 2030 | DENG, JIE | reporter.nih.gov |
| Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | NIH | National Cancer Institute | 2021 | $682,266 | September 1, 2017 | August 31, 2023 | PAUKSHTO, MICHAEL VITOLDOVICH | reporter.nih.gov |
| Lymphatic-adipocyte interactions in obesity and lymphedema | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $657,936 | June 1, 2022 | September 26, 2025 | WESTCOTT, GREGORY | reporter.nih.gov |
| Developing Imaging and Analysis Tools for Lymphoscintigraphy in Lymphedema | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $642,639 | September 1, 2025 | August 31, 2028 | YANG, JAEWON | reporter.nih.gov |
| Modifying adipocyte and pre-adipocyte cell fate in fibroadipose tissue of secondary lymphedema | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $518,280 | March 1, 2023 | February 28, 2028 | AGARWAL, SHAILESH | reporter.nih.gov |
| Engineered biomaterials for promoting lymphatic regeneration in lymphedema | NIH | National Heart, Lung, and Blood Institute | 2025 | $502,294 | June 3, 2025 | April 30, 2029 | DIXON, JAMES BRANDON | reporter.nih.gov |
| Role of Mast cells in regulating inflammatory pathology of secondary lymphedema | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $497,136 | July 23, 2025 | June 30, 2027 | KATARU, RAGHU PRASAD | reporter.nih.gov |
| Bioengineered lymphatic regenerating platform for treatment of breast cancer related lymphedema | NIH | National Heart, Lung, and Blood Institute | 2025 | $491,029 | June 20, 2025 | April 30, 2029 | VEISEH, OMID | reporter.nih.gov |
| High-Resolution Lymphatic Mapping of the Upper Extremities with MRI | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $489,100 | July 1, 2023 | June 30, 2027 | TSAI, LEO LEE | reporter.nih.gov |
| Visualizing vascular mechanisms of lipedema | NIH | National Heart, Lung, and Blood Institute | 2025 | $467,802 | January 25, 2025 | March 31, 2026 | CRESCENZI, RACHELLE L | reporter.nih.gov |
| Molecular mechanisms of Foxc-mediated angiogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 | $462,150 | July 1, 2018 | June 30, 2023 | KUME, TSUTOMU | reporter.nih.gov |
| Imaging sodium and lymphatics in lymphedema | NIH | National Heart, Lung, and Blood Institute | 2025 | $450,927 | January 25, 2025 | March 31, 2026 | CRESCENZI, RACHELLE L | reporter.nih.gov |
| Novel Mechanisms in the Resolution of Post-Surgical Lymphedema | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $446,277 | May 1, 2023 | April 30, 2028 | HASSANEIN, ALADDIN HASAN | reporter.nih.gov |
| Role of epidermis in regulating inflammatory skin manifestations of post-surgical lymphedema | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $422,499 | December 21, 2022 | November 30, 2024 | MEHRARA, BABAK J | reporter.nih.gov |
| Mechanisms of Junctional Proteins in Post-Surgical Lymphedema | NIH | National Heart, Lung, and Blood Institute | 2025 | $414,996 | August 15, 2025 | May 31, 2030 | HASSANEIN, ALADDIN HASAN | reporter.nih.gov |
| A Bioengineered Model for Deciphering Lymphatic Dysfunction in Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $400,200 | September 22, 2021 | August 31, 2024 | LEE, ESAK | reporter.nih.gov |
| TOPIC 435 - PHYSIOLOGICAL COMPRESSION THERAPY TO AUGMENT LYMPHATIC FUNCTION AND IMPROVE LYMPHEDEMA RESOLUTION. | NIH | National Cancer Institute | 2022 | $400,000 | September 15, 2022 | September 14, 2023 | WEILER, MICHAEL | reporter.nih.gov |
| Digital Surgical Magnification Device for Lymphatic Surgery | NIH | National Heart, Lung, and Blood Institute | 2021 | $399,846 | July 1, 2021 | December 31, 2022 | ASKARI KARCHEGANI, MAZIYAR | reporter.nih.gov |
| Prevention of Post-Surgical Lymphedema using Tissue Nanotransfection Technology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $383,574 | September 19, 2023 | August 31, 2025 | HASSANEIN, ALADDIN HASAN | reporter.nih.gov |
| Mechanisms underlying the formation of the cornea and ocular surface epithelium | NIH | National Eye Institute | 2021 | $378,923 | May 1, 2018 | April 30, 2023 | KUME, TSUTOMU | reporter.nih.gov |
| KATP channels and lymphatic dysfunction in Cantu Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 | $373,750 | August 1, 2018 | July 31, 2023 | DAVIS, MICHAEL JOHN | reporter.nih.gov |
| Understanding Quality of Life and Physical Activity in Black Breast Cancer Survivors | NIH | National Cancer Institute | 2022 to 2025 | $342,656 | May 17, 2022 | April 30, 2026 | BURSE, NATASHA RENEE | reporter.nih.gov |
| Ultrasound-Based Device to Guide Treatment of Lymphedema Using Skin Elasticity as a Biomarker | NIH | National Cancer Institute | 2021 | $256,514 | September 15, 2021 | August 31, 2023 | HOLLENDER, PETER | reporter.nih.gov |
| Use of skin grafts programmed to express VEGF-C with biosensor feedback regulation to treat lymphedema | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $214,382 | September 1, 2020 | February 29, 2024 | AGARWAL, SHAILESH | reporter.nih.gov |
| Regeneration and remodeling of collecting lymphatic vessels post-injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $212,250 | December 1, 2021 | November 30, 2024 | RAZAVI RIZI, MOHAMMAD | reporter.nih.gov |
| Microbiome profiling of non-healing filarial lymphedema wounds in Ghana. | NIH | Fogarty International Center | 2024 to 2025 | $178,596 | September 1, 2024 | August 31, 2029 | KWARTENG, ALEXANDER | reporter.nih.gov |
| Decoding the repair and immunomodulatory functions of lymphatic vessels in wound healing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $166,545 | August 1, 2024 | December 31, 2025 | KONIECZNY, PIOTR | reporter.nih.gov |
| Nurses Surviving Breast Cancer: An exploration of breast cancer diagnosis, reported lymphedema symptoms, and lifestyle status in the Nurses' Health Study Survey | NIH | National Cancer Institute | 2024 | $156,500 | September 13, 2024 | August 31, 2026 | ANDERSON, ELIZABETH A | reporter.nih.gov |
| The Consequence of Impaired Lymphatic Drainage on Rejection in Cardiac Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $140,482 | January 1, 2021 | December 31, 2023 | GINN, SYDNEY C | reporter.nih.gov |
| Investigating the Effectiveness and Mechanisms of Lymphaticovenous Anastomoses (LVA) for Lymphedema Treatment: Integrating Computational Modeling with Clinical LVA Insights | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $98,512 | May 15, 2024 | May 14, 2027 | RYU, YOUNG JAE | reporter.nih.gov |
| Mitigation of lymphatic injury by retinoic acid therapyin a large animal model | NIH | National Heart, Lung, and Blood Institute | 2021 | $88,000 | July 1, 2021 | June 30, 2023 | WONG, ALEX K. | reporter.nih.gov |
| High-Resolution Lymphatic Mapping of the Upper Extremities with MRI | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 | $60,515 | July 1, 2023 | August 31, 2023 | TSAI, LEO LEE | reporter.nih.gov |
| Unraveling the mechanisms behind lymphatic dysfunction in obesity: are weight-loss drugs effective at restoring lymphatic function? | NIH | National Heart, Lung, and Blood Institute | 2025 | $49,538 | August 12, 2025 | August 11, 2027 | SCHULZ, MARY E | reporter.nih.gov |
| Decoding the repair and immunomodulatory functions of lymphatic vessels in wound healing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $48,375 | January 1, 2024 | June 30, 2024 | KONIECZNY, PIOTR | reporter.nih.gov |
| The Second Heart Field in Lymphovenous Valve Development: Understanding Lymphatic Dysfunction in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $45,444 | December 27, 2024 | June 26, 2029 | VYZAS, CHRISTINA | reporter.nih.gov |
| Understanding Physical Activity and Quality of Life in Black Breast Cancer Survivors | NIH | National Cancer Institute | 2021 | $41,256 | August 6, 2020 | May 16, 2022 | BURSE, NATASHA RENEE | reporter.nih.gov |
| 2024 Lymphatics Gordon Research Conference and Seminar | NIH | National Heart, Lung, and Blood Institute | 2024 | $31,500 | February 1, 2024 | January 31, 2025 | CHEN, HONG | reporter.nih.gov |
| Regulation of lymphatic endothelial cell specification | NIH | National Heart, Lung, and Blood Institute | 2022 | $19,625 | July 1, 2022 | October 26, 2022 | MARZIANO, CORINA | reporter.nih.gov |
| Modulation of Lymphatic System Function by LTB4 | NIH | National Heart, Lung, and Blood Institute | 2021 | $17,536 | July 22, 2019 | December 21, 2021 | CRIBB, MATTHEW | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 33 | $14,710,980 | 0 | $0 |
| 2024 | 29 | $10,924,771 | 0 | $0 |
| 2023 | 26 | $9,940,593 | 0 | $0 |
| 2022 | 23 | $9,864,089 | 0 | $0 |
| 2021 | 30 | $12,387,557 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 2 awards here | |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.837 | December 3, 2026 | Not listed | Same assistance listing 93.837 as 38 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.837 | December 3, 2026 | Not listed | Same assistance listing 93.837 as 38 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.837 | December 4, 2026 | Not listed | Same assistance listing 93.837 as 38 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.837 | January 5, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.837 | January 5, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.837 | January 7, 2027 | $375,000 | Same assistance listing 93.837 as 38 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.837 | January 7, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) | PAR-25-025 | NIH | 93.837 | February 3, 2027 | $1.5 million | Same assistance listing 93.837 as 38 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) | PAR-25-026 | NIH | 93.837 | February 3, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
| Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) | PAR-27-125 | NIH | 93.837 | February 16, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
| Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) | RFA-DK-27-108 | NIH | 93.837 | March 10, 2027 | $500,000 | Same assistance listing 93.837 as 38 awards here |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) | PAR-25-032 | NIH | 93.837 | March 16, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.837 | April 5, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.837 | April 5, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
| Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) | RFA-OD-25-003 | NIH | 93.837 | April 9, 2027 | $200,000 | Same assistance listing 93.837 as 38 awards here |
| NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) | RFA-HL-26-002 | NIH | 93.837 | April 28, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
| NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) | RFA-HL-26-003 | NIH | 93.837 | April 28, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) | PA-24-175 | NIH | 93.837 | May 7, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.837 | May 7, 2027 | Not listed | Same assistance listing 93.837 as 38 awards here |
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.